Silence Therapeutics's total assets for Q4 2024 were £202.63M, an increase of 19.63% from the previous quarter. SLN total liabilities were £68.61M for the fiscal quarter, a -8.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.